Your search returned 4 results.

Results
	1.	Safety profile and immunogenicity of an inactivated vaccine derived from an attenuated strain of hepatitis A. [electronic resource] by Ellerbeck, E F Lewis, J A Nalin, D Gershman, K Miller, W J Armstrong, M E Davide, J P Rhoad, A E McGuire, B Calandra, G Producer: 19921015 In: Vaccine vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Cytotoxic properties of DAB486EGF and DAB389EGF, epidermal growth factor (EGF) receptor-targeted fusion toxins. [electronic resource] by Shaw, J P Akiyoshi, D E Arrigo, D A Rhoad, A E Sullivan, B Thomas, J Genbauffe, F S Bacha, P Nichols, J C Producer: 19911213 In: The Journal of biological chemistry vol. 266 Availability: No items available. Save to lists Add to cart (remove)
	3.	A putative sirolimus (rapamycin) effector protein. [electronic resource] by Chen, Y Chen, H Rhoad, A E Warner, L Caggiano, T J Failli, A Zhang, H Hsiao, C L Nakanishi, K Molnar-Kimber, K L Producer: 19940929 In: Biochemical and biophysical research communications vol. 203 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Development of the formalin-inactivated hepatitis A vaccine, VAQTA from the live attenuated virus strain CR326F. [electronic resource] by Armstrong, M E Giesa, P A Davide, J P Redner, F Waterbury, J A Rhoad, A E Keys, R D Provost, P J Lewis, J A Producer: 19940616 In: Journal of hepatology vol. 18 Suppl 2 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)